Technical note: Assessment of radiation measurement devices for the detection of [
[177Lu]Lu
[177mLu]Lu
detection limit
portable contamination monitor
release counter system
wastewater counter
Journal
Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
revised:
14
07
2022
received:
24
05
2022
accepted:
04
08
2022
pubmed:
9
10
2022
medline:
25
1
2023
entrez:
8
10
2022
Statut:
ppublish
Résumé
Nuclear medicine therapies using [ In this study, standard measurement hardware used for handling radioisotopes was evaluated for the measurement of [ The LODs were determined according to the international standard ISO 11929-1 for [ The average LOD across all PCMs was 0.249 ± 0.009 and 0.129 ± 0.005 Bq/cm All investigated measuring instruments (PCM, WWC, RCS) were suitable for the determination of [
Sections du résumé
BACKGROUND
BACKGROUND
Nuclear medicine therapies using [
PURPOSE
OBJECTIVE
In this study, standard measurement hardware used for handling radioisotopes was evaluated for the measurement of [
METHODS
METHODS
The LODs were determined according to the international standard ISO 11929-1 for [
RESULTS
RESULTS
The average LOD across all PCMs was 0.249 ± 0.009 and 0.129 ± 0.005 Bq/cm
CONCLUSIONS
CONCLUSIONS
All investigated measuring instruments (PCM, WWC, RCS) were suitable for the determination of [
Substances chimiques
Radiopharmaceuticals
0
Lutetium
5H0DOZ21UJ
Radioisotopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
590-599Subventions
Organisme : Federal Ministry of Education and Research
Organisme : Research Campus STIMULATE
ID : 13GW0473A
Informations de copyright
© 2022 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.
Références
Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discovery. 2020;19:589-608. doi:https://doi.org/10.1038/s41573-020-0073-9
Czernin J, Sonni I, Razmaria A, Calais J. The future of nuclear medicine as an independent specialty. J Nucl Med. 2019;60:3S-12S. doi:https://doi.org/10.2967/jnumed.118.220558
Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177 Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125-135. doi:https://doi.org/10.1056/NEJMoa1607427
Strosberg J, Wolin E, Chasen B, et al. Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177 Lu-Dotatate in the phase III NETTER-1 trial. J Clin Oncol. 2018;36:2578-2584. doi:https://doi.org/10.1200/JCO.2018.78.5865
Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385:1091-1103. doi:https://doi.org/10.1056/NEJMoa2107322
Dash A, Pillai MRA, Knapp FF. Production of (177)Lu for targeted radionuclide therapy: available options. Nucl Med Mol Imaging. 2015;49:85-107. doi:https://doi.org/10.1007/s13139-014-0315-z
Hennrich U, Kopka K. Lutathera®: the first FDA- and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy. Pharmaceuticals. 2019;12:114. doi:https://doi.org/10.3390/ph12030114
Kondev FG. Nuclear data sheets for A = 177. Nucl Data Sheets. 2003;98:801-1095. doi:https://doi.org/10.1006/ndsh.2003.0006
Kondev FG, Ahmad I, Carpenter MP, et al. Gamma-ray emission probabilities in the decay of (177m)Lu. Appl Radiat Isot. 2012;70:1867-1870. doi:https://doi.org/10.1016/j.apradiso.2012.02.029
Gleisner KS, Brolin G, Sundlöv A, et al. Long-term retention of 177Lu/177mLu-Dotatate in patients investigated by gamma spectrometry and gamma camera imaging. J Nucl Med. 2015;56:976-984. doi:https://doi.org/10.2967/jnumed.115.155390
Khan S, Syed A, Ahmad R, Rather TA, Ajaz M, Jan F. Radioactive waste management in a hospital. Int J Health Sci. 2010;4(1):39-46.
United States Nuclear Regulatory Commission. NRC, 10 CFR, 35.92 Decay-in-storage. . Accessed May 23, 2022. https://www.nrc.gov/reading-rm/doc-collections/cfr/part035/part035-0092.html
Groch MW. Radioactive Decay. Radioactive decay. RadioGraphics. 1998;18:1247-1256. doi:https://doi.org/10.1148/radiographics.18.5.9747617
DIN ISO 11929-1 VDE 0493-9293:2020-03. Determination of the characteristic limits (decision threshold, detection limit and limits of the coverage interval) for measurements of ionizing radiation - fundamentals and application (German Language Version), Beuth-Verlag, Berlin. 2020.
Wanke C, Geworski L. Conservative calibration of a clearance monitor system for waste material from nuclear medicine. Z Med Phys. 2014;24:252-260. doi:https://doi.org/10.1016/j.zemedi.2014.01.001
Federal Office for Radiation Protection. Bundesamt für Strahlenschutz - BfS). Ordinance on the protection against damage and injuries caused by ionizing radiation. Appendix 4, Table 1, Column 3 and 5, Appendix 11, Table 6, Column 3. 2018. Accessed May 23, 2022. https://www.gesetze-im-internet.de/strlschv_2018/index.html
Pourtangestani K, Machrafi R. Optimization of plastic scintillator thicknesses for online beta/gamma detection. EPJ Web of Conferences. 2012;24:07010. doi:https://doi.org/10.1051/epjconf/20122407010
DIN ISO 7503-3 VDE 0493-2-5033:2017-12. Measurement of radioactivity - measurement and evaluation of surface contamination - Part 3: Apparatus calibration (ISO 7503-3:2016) (German Language Version), Beuth-Verlag, Berlin. 2017.